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Abstract : Pulmonary vein isolation （PVI） via catheter ablation has been shown to 
be a highly effective option for patients with symptomatic paroxysmal atrial bril-
lation （AF）.  The recurrence of AF within 3 months after PVI is not considered 
a failure of the ablation procedure because early recurrence of AF is not always 
associated with late recurrence.  We examined the usefulness of an external loop 
recorder with auto-trigger function （ELR-AUTO） to detect AF following PVI to 
characterize early recurrence and determine the implication of AF within 3 months 
after PVI.  The study included 53 consecutive patients with symptomatic paroxys-
mal AF （age, 61.6 ± 12.6 years ; 77％ male） who underwent PVI, and were tted 
with an ELR-AUTO for 7 ± 2 days within 3 months after PVI.  Of the 33 patients 
（62.2％） who did not have AF within the 3-month period, only 1 patient had AF 
recurrence at 12 months.  Seven of 20 patients （35％） who experienced AF within 
3 months had symptomatic AF recurrence at 12 months.  The sensitivity, specic-
ity, positive predictive value, and negative predictive value of early AF recurrence 
for late recurrence was 87.5％, 71.1％, 35.0％, and 96.9％, respectively.  Thus, AF 
recurrence detected by ELR-AUTO within 3 months after PVI can predict late AF 
recurrence.  Freedom from AF in the rst 3 months following ablation signicantly 
predicts long-term freedom from AF.  An ELR-AUTO is useful for detecting 
symptomatic and asymptomatic AF.
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Introduction
　Pulmonary vein isolation （PVI） via catheter ablation has been shown to be a highly effective 
option for patients with symptomatic paroxysmal atrial fibrillation （AF）.  The recurrence of 
AF in the 3-month period after PVI is common and is not considered a procedure failure of 
catheter ablation because the early recurrence of AF in this period is not always associated with 
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late AF recurrence.  Therefore, this period has been called “the blanking period” 1, 2）.  However, 
the clinical significance of early recurrence is controversial because most studies determine AF 
recurrence based on patients’ symptoms 3）.  The incidence of symptomatic and asymptomatic AF 
recurrence within 3 months after PVI is not well described.
　SpiderFlash-tTM A-Fib （Sorin Group, Clamart, France） is an external loop recorder with an 
auto-trigger function （ELR-AUTO）, which detects and records any arrhythmia automatically. 
We examined the usefulness of the ELR-AUTO to detect AF within 3 months after PVI to 
characterize early recurrence and to determine the implication of AF within 3 months after PVI.
Methods
Study subjects
　Fifty-three consecutive patients who underwent PVI at our hospital, and were monitored with 
an ELR-AUTO within 3 months after catheter ablation were enrolled in this study from April 
2012 to December 2012.  The patients all had highly symptomatic AF which was refractory to 
drugs.  Medical histories were obtained from patient interviews and medical records, such as 
electrocardiograms （ECGs） and Holter monitors depicting episodes of AF.  Written informed 
consent was obtained from all subjects before catheter ablation.
Catheter ablation
　Any new oral anticoagulant drug was discontinued on the day of the procedure.  Warfarin was 
discontinued 3 days before the procedure.  The PVI catheter ablation procedure was performed 
with electrode catheters placed in the high right atrium, coronary sinus, and His bundle 
region.  The left atrium （LA） was approached via an atrial septal puncture under the guidance 
of intravascular ultrasound.  After performing an atrial trans-septal puncture, heparin was 
administered, and an activated clotting time of 350 seconds was maintained.  Three-dimensional 
mapping was performed using either a CARTO （Biosense Webster, Diamond Bar, CA） or NavX 
（St. Jude Medical, St. Paul, MN） system, and then a LASSO （Biosense Webster） catheter was 
placed in the PV, and an ablation application was delivered via an irrigation catheter, with a 
power setting of 30-35 W on the anterior wall and 20-25 W on the posterior wall.  The end-
point of the ablation was a bidirectional block at the PV-LA antrum.  The procedure was 
considered complete when no arrhythmia induction occurred during programmed stimulation 
（cycle length, 200 msec）.
Post-ablation evaluation
　For the clinical follow-up, patients were fitted with an ELR-AUTO for 1-2 weeks within 3 
months of undergoing ablation.  AF burden within 3 months after ablation was defined as early 
AF recurrence if AF lasted for 60 seconds with or without symptoms.  Symptomatic AF was 
defined as AF-related symptoms with palpitations and chest discomfort.
　The patients visited the hospital at 1-month intervals, and underwent an ECG recording. 
Late recurrence of AF was evaluated by the 12-lead ECG, Holter ECG, or ELR-AUTO.  Late 
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recurrence was defined as AF which was detected by any method 12 months after ablation.
External loop recorder
　The ELR-AUTO was fitted by a medical technician on the first day only, and the patients 
were then instructed how to attach the device themselves on subsequent days.  The patients 
put one cathode （white） and two anode （red and brown） patches on their body surface.  The 
frequency characteristics of the ECG recordings were from 0.05-80 Hz, the dynamic range of the 
input was ± 16 mV / ± 300 mV, the carrier frequency was 200 Hz, and the resolution was 10 µV.
　The arrhythmia detection function of the loop recorder was set to record the ECG for 2 
minutes after an event and 4 minutes before an event when the patient noticed a symptom and 
pressed the button of the device.  For asymptomatic events, the automatic detection function of 
the ELR-AUTO recorded the ECG according to the settings shown in Table 1.  All patient-
activated events were symptomatic, but all auto-triggered were not only asymptomatic events. 
The device registered an auto-triggered event at the same time as it was recording for a patient-
activated event.
Statistical analysis
　The continuous variables were expressed as the mean ± standard deviation.  A P-value of＜
0.05 was used to determine significant differences.  For statistical analyses, JMP software （version 
10.0 ; SAS Institute, Cary, NC） was used.
Results
Patient characteristics
　Patient characteristics are shown in Table 2.  The 53 patients included 41 men and 12 women, 
with a mean age of 61.6 ± 12.6 years, and an average disease duration of 4.6 ± 4.4 years.  The 
echocardiography findings revealed that the average LA diameter was 43.6 ± 6.1 mm and the 
average ejection fraction was 61.2％± 5.9％.
Table 1.　Automatic detection function settings for ELR-AUTO
Disorder Threshold Minimum duration （sec） Time before （sec） Time after （sec）
SV tachycardia （bpm）  160 10 60  60
Irregular RR interval 60 60 120
％ RR interval for PAC 　75
Ventricular tachycardia （bpm）  140  8 60  60
％ RR interval for PVC 　85
Bradycardia （bpm） 　40 20 60  60
Pause （msec） 3000 10  10
Missed beats （msec） 1000 10  10
ELR-AUTO, external loop recorder with auto-trigger function ; SV, supraventricular ; PAC, premature atrial contrac-
tion ; PVC, premature ventricular contraction.
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Catheter ablation
　There were 51 patients with complete isolation and 2 patients with incomplete isolation. 
In these 2 patients, we were able to confirm only a unidirectional block and we ended the 
procedure due to the long procedure time.  A LA roof and mitral isthmus linear ablation was 
performed in 6 patients because AF was induced by programmed atrial stimulation after PVI. 
When common atrial flutter was induced by programmed atrial stimulation, cavo-tricuspid isthmus 
linear ablation was performed （n＝18）.
AF within three months after ablation
　AF was recorded by the ELR-AUTO in 20 of 53 patients （37.7％）; there was no significant 
difference in gender, age, echocardiographic findings, oral medications, or underlying disease 
between patients with and without early AF recurrence.  Ten of 20 patients （50％） with early 
AF recurrence had both symptomatic and asymptomatic AF burden, whereas 10 （50％） had only 
asymptomatic AF burden.  Table 3 shows the symptomatic and asymptomatic AF recurrence 
group （n＝10） and the asymptomatic AF recurrence only group （n＝10） from among the 
patients in which AF was detected by ELR-AUTO monitoring.  There was no significant 
difference in gender, age, echocardiographic findings, oral medications, or underlying disease 
between these two groups.  However, patients with symptomatic AF burden had a longer history 
of paroxysmal AF than patients with asymptomatic AF （6.1 ± 3.6 vs. 2.1 ± 2.1 years, respectively ; 
P＜＝0.01）.  In addition, E / e' （the ratio between the velocity of the E and A waves on 
Table 2.　Patient Characteristics
Characteristic Total（n＝ 53）
Male : female 41 : 12
Age （y）＊ 61.6 ± 12.6
Disease duration （y）＊ 4.6 ± 4.4
Echocardiography
　Left atrial diameter （mm）＊ 43.6 ± 6.1
　Left ventricular ejection fraction （％）＊ 61.2 ± 5.9
　DcT （msec）＊ 218.2 ± 60.4
　E / e'＊ 7.2 ± 6.2
Anti-arrhythmic drug 27
Underlying disease
　Hypertension 23
　Diabetes Mellitus  5
　Dyslipidemia 16
　Congestive heart failure  9
DcT, deceleration time ; E / e', ratio between velocity of E 
and A waves on Doppler transmitral ow.
Values are n unless otherwise indicated ; ＊mean ± standard 
deviation.
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Doppler transmitral flow） was higher in patients with symptomatic AF burden than in patients 
with asymptomatic AF （7.0 ± 1.1 vs. 5.5 ± 1.0, respectively ; P＜ 0.01）.
Patient-activated ELR-AUTO recorded events
　Patients activated the ELR-AUTO for a total of 391 events.  Fig. 1 demonstrates the ECG 
recordings for the different events.  Out of the 391 events, 177 events （45.2％） were normal 
Table 3.　Symptomatic and asymptomatic AF
Characteristic
ER＋ Symptom＋
（n＝ 10）
ER＋ Symptom-
（n＝ 10）
P-value
Male : female 9 : 1 7 : 3 n.s
Age （y）＊ 59.4 ± 13.8 63.4 ± 8.0 n.s
Disease duration （y）＊ 6.1 ± 3.6 2.1 ± 2.1 0.01
Echocardiography
　LA diameter （mm）＊ 46.2 ± 7.9 42.7 ± 5.0 n.s
　LV ejection fraction （％）＊ 61.7 ± 9.3 62.8 ± 4.9 n.s
　DcT （msec）＊ 197.8 ± 68.4 234.0 ± 71.0 n.s
　E / e'＊ 7.0 ± 1.1 5.5 ± 1.0 0.01
Anti-arrhythmic drug 7 5 n.s
Underlying disease
　Hypertension 4 7 n.s
　Diabetes mellitus 1 2 n.s
　Dyslipidemia 1 5 0.04
　Congestive heart failure 0 2 n.s
AF, atrial fibrillation ; ER, early recurrence ; ER＋ Symptom＋, symptomatic and 
asymptomatic early AF recurrence ; ER＋ Symptom-, asymptomatic early AF recur-
rence ; LA, left atria ; LV, left ventricle ; DcT, deceleration time ; E / e', ratio between 
velocity of E and A waves on Doppler transmitral ow ; n.s, not signicant.
Values are n unless otherwise indicated ; *mean ± standard deviation.
Fig. 1.  Patient-activated ELR-AUTO recorded events. 
Pie chart showing the number and percentage of 
different events recorded when the patients felt 
symptoms. A total of 393 events were detected, 
with 43 events （11％） being recording failure 
events. ELR-AUTO, external loop recorder with 
auto-trigger function ; NSR, normal sinus rhythm ; 
PAC, premature atrial contraction ; AF, atrial 
fibrillation ; PVC, premature ventricular contraction ; 
MB, missed beats.
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sinus rhythm （NSR）, 88 events （22.5％） were premature atrial contractions （PACs）, 45 events 
（12.5％） were AF, 37 events （9.4％） were premature ventricular contractions （PVCs）, and 43 
events （10.9％） could not be identified because of high background noise.
Automatic ELR-AUTO recorded events
　Fig. 2 shows a total of 5775 recordings which were obtained by the ELR-AUTO automatically. 
Each recording was confirmed and categorized by a specialist physician.  Out of the 5775 
recordings, 2374 recordings （41.1％） were noise, 1492 recordings （25.8％） were AF, 1349 
recordings （23.3％） were PACs, 270 recordings （4.6％） were PVCs, 251 recordings （4.3％） were 
missed beats, 16 recordings （0.27％） were pauses, 15 recordings （0.26％） were bradycardia, 4 
recordings （0.06％） were supraventricular tachycardia, and 4 recordings （0.06％） were ventricular 
tachycardia.
Number of AF events each day
　A total of 1537 symptomatic and asymptomatic AF events were recorded by the ELR-AUTO 
in 20 patients.  Fig. 3 shows the incidence of AF each day during the ELR-AUTO monitoring. 
Symptomatic AF was recorded 45 of 1537 times （2.9％） that AF was recorded.
Fig. 2.  Automatic ELR-AUTO recorded events. Pie chart 
showing the number and percentage of different 
asymptomatic events automatically detected. There 
was a total of 5728 events, including 2374 （42％） 
recording failure events. ELR-AUTO, external 
loop recorder with auto-trigger function ; AF, atrial 
fibrillation ; PAC, premature atrial contraction ; PVC, 
premature ventricular contraction ; MB, missed 
beats ; Brady, bradycardia ; NSVT, non-sustained 
ventricular tachycardia ; SVT, supraventricular 
tachycardia.
Fig. 3.  Atrial fibrillation （AF） burden each day. Histogram 
showing the total number of AF events each day 
over a 7-day period in the 20 patients in whom 
early paroxysmal AF recurrence was observed. 
Blue bars are patient-activated （PA） events ; red 
bars are auto-triggered （AT） events.
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Early AF and late symptomatic AF
　Fig. 4 shows the results of the long-term follow-up of the patients with early recurrence 
（n＝20） and those without early recurrence （n＝33） of AF.  There was no significant difference 
between the two groups for age, disease duration, echocardiographic findings, underlying disease, 
or late recurrence, however, there was a significantly lower incidence of late AF recurrence at 12 
months in patients without any early AF recurrence.
　Table 4 shows the characteristics of patients with and without late AF recurrence at 12 
months.  There was no significant difference between the two groups for age, disease duration, 
Fig. 4.  Long-term follow-up results. Schema showing number and 
percentage of patients with early and late atrial fibrillation （AF） 
recurrence.
ER＋, early AF recurrence within 3 months after pulmonary 
vein isolation （PVI）; ER-, early AF recurrence absent ; LR＋, 
late AF recurrence at 12 months after PVI ; LR-, late AF 
recurrence absent.
Table 4.　Late AF recurrence
Characteristic LR＋ （n＝ 8） LR- （n＝ 45） P-value
Male : female 8 : 0 33 : 12 0.003
Age （y）＊ 61.6 ± 6.9 61.6 ± 13.5 n.s
Disease duration （y）＊ 6.1 ± 4.2 4.7 ± 4.6 n.s
Echocardiography
　LA diameter （mm）＊ 47.6 ± 6.3 42.9 ± 5.9 0.04
　LV ejection fraction （％）＊ 59.2 ± 6.8 61.5 ± 5.8 n.s
　DcT （msec）＊ 204.0 ± 49.6 220.8 ± 62.3 n.s
　E / e'＊ 5.7 ± 1.2 7.6 ± 6.5 n.s
Anti-arrhythmic drug 5 22 n.s
Underlying disease
　Hypertension 5 18 n.s
　Diabetes mellitus 1  4 n.s
　Dyslipidemia 2 14 n.s
　Congestive heart failure 1  8 n.s
AF, atrial brillation ; LR, late recurrence ; LA, left atria ; LV, left ventricle ; 
DcT, deceleration time ; E / e', ratio between velocity of E and A waves on 
Doppler transmitral ow ; n.s, not signicant.
Values are n unless otherwise indicated ; ＊mean±standard deviation.
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or underlying disease, however, there was a significantly smaller LA diameter and lower male to 
female ratio in patients without any late AF recurrence.
　Late recurrence of AF occurred in 8 of 53 patients （15％）.  Seven of the 20 patients （35％） 
who experienced AF within 3 months after PVI had symptomatic AF recurrence at 12 months. 
The sensitivity, specificity, positive predictive value, and negative predictive value of early AF 
recurrence for late AF recurrence was 87.5％, 71.1％, 35.0％, and 96.9％ respectively.
Discussion
Main Findings
　Most AF events were asymptomatic and freedom from AF in the first 3 months following 
PVI predicts long-term AF freedom.
AF recurrence within three months after PVI
　To our knowledge, there are no previous reports evaluating the recurrence of AF within 3 
months after PVI using the ELR-AUTO.  Previous trials reported that the recurrence rate of 
AF within 3 months after PVI was 35％～65％1, 4-7）.  In these trials, several different recording 
systems, such as Holter ECG monitors, event recorders, trans-telephonic monitoring, external loop 
recorders or implantable loop recorders （ILR）, were used to identify AF recurrence.  We could 
not compare these trials because the type of patient, ablation strategy, definition of recurrence, or 
ECG monitoring was different among these trials.  However, the longer the monitoring time, the 
higher the detection rate of AF recurrence.  In addition, continuous monitoring is necessary to 
detect AF recurrence because most AF after PVI is asymptomatic.
　A predictor of recurrence was not identified, as in the previous trials 2）.  A few papers have 
reported that incomplete PVI is a predictor of recurrence 2, 8）.  Only 2 patients had incomplete 
isolation in this study, but they did not have early AF recurrence or late recurrence.  It is 
possible that unidirectional block contributes to the suppression of the trigger and perpetuation 
of AF, while PVI has the effect of local denervation of the ganglionic plexus around the 
superior PV-LA junction during the ablation procedure 9）.
Symptomatic and asymptomatic AF
　In the present study, the presence or absence of symptoms during AF recurrence was 
examined.  The symptomatic AF recurrence group had significantly longer disease duration 
and higher E / e' compared to the asymptomatic AF recurrence group.  E / e' reflects diastolic 
dysfunction.  Kosiuk et al 10） reported diastolic dysfunction is correlated with symptom severity 
in AF.  A possible explanation of that observation would be the strong dependence of the 
hemodynamic performance of the whole system on intact atrial function, since the functional 
reserve of the impaired left ventricle is highly reduced.
　Neumann et al 5） also examined the detection of symptomatic AF using a portable ECG event 
recorder in patients that underwent PVI, and reported the detection of AF by symptoms was 
inaccurate.  Verma et al 11） reported that according to the evaluation of ILRs, the incidence of 
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asymptomatic AF was 52.0％ before PVI, but increased to 79.0％ after PVI.  After PVI, the 
number of AF events, duration of AF, and heart rate variability were decreased.  In the present 
study, the incidence of asymptomatic AF was 97％ ; therefore, we concluded that AF recurrence 
after PVI could not be evaluated by the patient’s symptoms.
Early and late AF recurrence
　In the present study, we hypothesized that patients having early AF recurrences would have a 
significant trend toward also having late AF recurrences.  Oral et al 3） and Joshi et al 1） reported 
that AF recurrence 2 weeks after ablation was the predictor of late phase recurrences.  In 
addition, Joshi et al 1） reported that AF recurrence from 2 weeks to less than 3 months was 
not related to late recurrence.  On the other hand, Choi et al 12） reported that early recurrence 
within 3 months after PVI was associated with late AF recurrences.  In those studies, early 
recurrence was correlated with late recurrence.  In this study, our results were similar.  But the 
positive predictive value was very low, while the negative predictive value was high.  However 
this finding is promising.  Freedom from atrial fibrillation in the first 3 months following PVI 
predicts long-term AF freedom.  In the previous studies, ILRs, telephonic monitoring, external 
loop recorders or Holter monitors detected AF over a long term, but as shown in our study, 
using the ELR-AUTO for only 1 week might predict late recurrence.  Because most of the AF 
burden was asymptomatic, the auto-trigger function was also useful 1, 3-7）.
Usefulness of ELR-AUTO to identify AF recurrence
　It is currently believed that Holter and trans-telephonic monitoring are the main modalities 
to identify arrhythmia recurrence.  However, Ziegler et al 13） reported that intermittent and 
symptom-based monitoring had lower sensitivity and lower negative predictive value for the 
identification of patients with AF, and underestimated AF burden compared to continuous 
monitoring.  Verma et al 11） evaluated AF recurrence after PVI using ILRs, and reported that 
the proportion of asymptomatic events increased after PVI.  Kapa et al 7） also used ILRs after 
catheter ablation to investigate early and late recurrence of AF.  They reported that in 1-6 
months, the rate of AF recurrence was 47％ and in 6-12 months, the rate of AF recurrence 
was 18％.  Reiffel et al 14） investigated the Holter ECG monitors, ELRs, and automatic detection 
function ELRs and reported that the auto-detection ELRs were useful for the detection of 
asymptomatic arrhythmias.  Continuous monitoring is necessary to identify AF recurrence. 
Martinez and Sztajzel 15） also reported the usefulness of the ELR for arrhythmia diagnoses, and 
both groups were able to reach a diagnosis in an average of 5 days.  As asymptomatic events 
are reported to increase after PVI, an ELR-AUTO with an automatic detection function would 
be useful for the evaluation of arrhythmias after catheter ablation.
Limitations
　This was a retrospective study and the number of cases was small.  The recordings may be 
illegible because of high noise.  The physicians and laboratory technicians confirmed all of the 
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waveforms.  In addition, the algorithm for the detection of an irregular RR interval using the 
ELR-AUTO has not been published.  Therefore some instances of AF might be missed.
　In conclusion, AF recurrence in the period within 3 months after PVI can predict the 
response to catheter ablation at 12 months.  Freedom from AF in the first 3 months following 
ablation significantly predicts long-term AF freedom. The ELR-AUTO is useful for detecting 
symptomatic and asymptomatic AF.
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